BNET Industries
pfizer inc. - All News and Analysis
Dell Shifts Manufacturing From Ireland to Poland
By Andras GergelyDUBLIN (Reuters UK) - Dell DELL, the world's No. 2 PC maker, is shifting its European manufacturing base from Ireland to Poland and cutting 1,900 of 3,000 jobs at its Limerick plant in a bleak start to the year for the shrinking Irish economy.Dell, which ranks itself as...
Rigel Still on Track, And Has Pfizer Found Its Next Blockbuster?
Ohad Hammer submits: In the pharmaceutical industry, 2008 will probably be marked by the big pharmas’ insatiable appetite for new drugs. Threatened by fierce generic competition, the pharmaceutical giants were not only eager to pay generous acquisition premiums for marketed products, but were also willing to pay a lot of...
Pharma Roundup: Pfizer's Lipitor Patent, Wyeth and Crucell, and More
Court re-validates Pfizer's Lipitor patent; Wyeth wants to buy Crucell; new spin-off Facet cuts jobs; Merckle family to sell Ratiopharm. by John Maas
The Pfizer-Shire Deal Worst-Case Scenario
Earlier this week shares of Shire rose on rumors that Pfizer may be interested in acquiring the company, which is best-known for its ADHD drug Adderall XR. The notion that Pfizer is in acquisition mode has been driving people crazy for days. (See BNET's coverage of Pfizer Pfever here.) ...
Why I Pick on Pfizer
Derek Lowe submits: I get occasional comments and e-mails asking why I’m so hard on Pfizer PFE. It’s not that I have anything personal against the company – I’ve never worked there, and they’ve never turned me down for a job. And I have a lot of friends there...
Pfizer's Big Acquisition ... Is a Tiny Rights Deal With Cytos
The world continues to fuliminate over the notion that Pfizer is poised to make a big deal. Could it be Amgen? Could it be Bristol-Myers Squibb? The speculation reached a new height of ridiculousness with this column in Today's Financial News, "Pfizer shouts its message to the...
List of 56 Drugs That Should Not Be Mixed With Viagra Contains Some Surprises
Public Citizen has published a list of 56 drugs that interact badly with erectile dysfunction pills such as Pfizer's Viagra. Public Citizen's WorstPills.com site reports: In combination with ED drugs, these 56 drugs can cause dangerous falls in blood pressure that could lead to a heart attack or stroke;...
Pharma Roundup: Pfizer's Acquisition Plans, Prasugrel's Big Day, and More
Pfizer wants acquisitions, big and small. Prasugrel has a date with the FDA. New Year's blog feature bonanza. Farewell, Pharmalot. by John Maas
Starved of News, Press Speculates on Deals for Abbott, Pfizer and Wyeth
New Year is a slow news period, which is why the business press filled up with next-to-useless coporate strategy stories about Abbott Labs, Wyeth and Pfizer. The one thing these stories all have in common? They're long on speculation and short on substance. Let's take them one at a time....
Is Pfizer Now Interested in a Merger?
Mike Huckman submits: AP The "Financial Times" apparently got a one-on-one interview with Pfizer PFE Chairman and CEO Jeff Kindler and is playing up what he said with the headline, "Pfizer eyes merger deal with large rival." That conclusion is based on this quote: "We are open to opportunities and...
Pfizer Chief Open to Acquisitions: Report
(Reuters) - Pfizer Inc PFE, the world's biggest pharmaceutical group, is open to acquisitions, its chief executive Jeff Kindler told the Financial Times in an interview."The real goal is to grow revenues ... We are open to opportunities and constantly looking at those which are big, small and in-between," Kindler...
Let Them Eat Sushi! 14,000 Layoffs, But Pfizer Lobbyist Dines on $15 Raw Fish Rolls
Pfizer has laid off 14,000 people over the last two years, doubtless causing some folks to cut back on discretionary expenses. But Pfizer lobbyist Donna Kaylor is still eating $15 sushi rolls in Sacramento, Calif. Kaylor got herself named in the Sacramento News & Review's restaurant section when she accompanied...
Pfizer: A Case Study of the Market's Extremely Low Valuations
Eddy Elfenbein submits: I want to show you the dramatic collapse in stock valuations by taking a close look at Pfizer PFE, the drug company. I’m not recommending the shares to own, I simply want to show you how extreme the market’s judgments have become. On Monday, shares of...
Pfizer Trovan Case: Doctor Sues Over Link to Nigerian Attorney General Who Allegedly Wants Slice of Settlement
A Texas doctor helping the Nigerian government in its claim against Pfizer in the Trovan drug testing case has sued an African investigative reporting website, SaharaReporters, for $25 million, according to Black Star News. SaharaReporters had written that the doctor was a cousin of Nigeria's attorney general and that the...
The 10 Weirdest Drug Stories of the Month
It's the last weekend of the month and, per tradition, BNET brings you its weirdest drug stories of December 2008 -- all the news that was too minor to mention at the time, but too strange to go unnoted. Doc lets Botox prices fall and rise with...
Pfizer Gives Sangamo a Vote of Confidence
Sangamo SGMO announced today it received an upfront payment of $3M from Pfizer PFE in exchange for a world-wide, perpetual, non-exclusive license for the use of certain ZFP Nuclease (ZFN) reagents to permanently eliminate the Glutamine Synthetase (GS) gene in Chinese Hamster ovary CHO cell lines. Shares are...
S&P Says GE Triple-A Could Be at Risk
By Scott Malone and Karen BrettellBOSTON/NEW YORK (Reuters) - Standard & Poor's lowered its outlook on General Electric Co GE to "negative" on Thursday, meaning it believes there is a one-in-three chance the U.S. conglomerate could lose its coveted "AAA" rating over the next two years.The ratings agency upheld its...
Pfizer to Sell Penis-Straightening Drug
Pfizer, the maker of Viagra, has struck a deal to sell Xiaflex, a drug that cures curvature of the penis ... There's just one drawback to Xiaflex -- it's administered by injection. by Jim Edwards
The Pfizer-Amgen Deal Worst-Case Scenario
Deutsche Bank analyst Barbara Ryan has again gone public with her desire to see Pfizer get off its pile of cash and make a dramatic mega-buy that would solve its pipeline hole. This time she thinks Amgen ought to be the target. BNET readers have been down this road before....
Pfizer Donated to Senators Who Supported H-1B Visa Expansion
Pfizer donated tens of thousands of dollars to Sens. Chris Dodd and Joe Lieberman of Connecticut, and those senators supported an expansion of the H-1B visa program that allows foreign workers to beĀ brought to the US to do technical jobs, according to New London's The Day. Coincidentally, Pfizer has...
Sort byClose
View by Content TypeClose
View by Related Tag Close
- Stock (176 results)
- Finance (122 results)
- Sales (98 results)
- Patient (94 results)
- Healthcare (83 results)
- Merck & Co. Inc. (79 results)
- Company (79 results)
- Health Care (75 results)
- Investment (75 results)
- FDA (69 results)
- Pharmaceutical Company (67 results)
- Marketing (58 results)
- Software (56 results)
- Advertisement (53 results)
- Agreement (50 results)
- Nasdaq Stock Market Inc. (50 results)
- Johnson & Johnson (50 results)
- New York Stock Exchange (50 results)
- Government (49 results)
- merger (48 results)
- Patent (43 results)
- Lipitor (41 results)
- Acquisition (40 results)
- Benefits (39 results)
- Jim Edwards (37 results)
- collaboration (36 results)
- Agence France-Presse (36 results)
- blog (35 results)
- R&D (35 results)
- Industry (35 results)
- Biotechnology (33 results)
- Hackensack (32 results)
- Eli Lilly & Co. (31 results)
- Webcast (30 results)
- GlaxoSmithKline Plc. (30 results)
- Job (30 results)
- board (29 results)
- Bristol-Myers Squibb Co. (29 results)
- Manufacturing (28 results)
- Cisco Systems Inc. (28 results)
- Microsoft Corp. (27 results)
- Wyeth (26 results)
- Strategy (26 results)
- General Motors Corp. (25 results)
- Warner-Lambert (25 results)
- Novartis AG (23 results)
- General Electric Co. (22 results)
- Schering-Plough Corp. (21 results)
- Applied Materials Inc. (21 results)
- Palm Inc. (20 results)

- Revenue (Fiscal Year) $48.4B
- Profit (Fiscal Year) $8.1B
- Incorporated: 1942
- CEO: Mr. Jeffrey B. Kindler
Pfizer discovers, develops, produces and markets prescription medicines for humans and animals. Co. has two segments: Pharmaceutical, which develops and produces products that treat cardiovascular and metabolic diseases, central nervous system disorders, arthritis and pain, infectious and respiratory diseases, urology, oncology, ophthalmology, and endocrine disorders; and Animal Health, which discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. Co. also operates several other businesses, such as the manufacture of gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals.
Competitors
Stock Quote
Board of Directors
Mr. Jeffrey B. Kindler Chairman
Mr. William R. Howell
Mr. James M. Kilts
Mr. George A. Lorch
Mr. Dana G. Mead
Ms. Suzanne Nora Johnson
Mr. William C. Steere Jr. Chairman Emeritus
Dr. Dennis A. Ausiello M.D.
Dr. Michael S. Brown M.D.
Mr. M. Anthony Burns
Mr. Robert N. Burt
Mr. W. Don Cornwell
Mr. William H. Gray III
Ms. Constance J. Horner
NAICS Code
Pharmaceutical Preparation Manufacturing: 325412
Industry Transcripts by Seeking Alpha
-
Immucor Inc. F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Jan 08, 2009about BLUD
-
Neogen Corporation F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Jan 06, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q09 (Qtr End 11/30/08) Earnings Call Transcript
on Dec 16, 2008about WNI
-
AVANIR Pharmaceuticals F4Q08 (Qtr End 10/31/08) Earnings Call Transcript
on Dec 15, 2008about AVNR
-
Martek Biosciences Corporation F4Q08 (Qtr End 10/31/08) Earnings Call Transcript
on Dec 11, 2008about MATK